These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 7027408

  • 1. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
    Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Touboul D, Touboul PJ.
    Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
    [No Abstract] [Full Text] [Related]

  • 2. [Controlled cooperative trial. Secondary prevention of atherosclerosis-related cerebral ischemic accidents by aspirin dipyridamole. 2: Description of subjects at the beginning of the trial].
    Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Thibult N, Touboul D, Touboul PJ.
    Rev Neurol (Paris); 1982; 138(1):1-15. PubMed ID: 7048482
    [Abstract] [Full Text] [Related]

  • 3. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J.
    J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153
    [Abstract] [Full Text] [Related]

  • 4. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC.
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract] [Full Text] [Related]

  • 5. [Secondary prevention after stroke. Doubled performs better].
    MMW Fortschr Med; 2003 Nov 13; 145(46):49. PubMed ID: 14699837
    [No Abstract] [Full Text] [Related]

  • 6. [The A.I.C.L.A. controlled cooperative trial. Secondary prevention of cerebral ischemic accidents due to atherosclerosis by aspirin and dipyridamole. 3: Results].
    Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Thibult N, Touboul D, Touboul PJ.
    Rev Neurol (Paris); 1983 Nov 13; 139(5):335-48. PubMed ID: 6351216
    [Abstract] [Full Text] [Related]

  • 7. Combination antiplatelet agents in ischemic cerebrovascular disease.
    Moussouttas M, Papamitsakis N.
    Mt Sinai J Med; 2005 Jan 13; 72(1):16-22. PubMed ID: 15682258
    [Abstract] [Full Text] [Related]

  • 8. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP, Saseen JJ.
    Pharmacotherapy; 2008 Oct 13; 28(10):1233-42. PubMed ID: 18823219
    [Abstract] [Full Text] [Related]

  • 9. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL.
    J Stroke Cerebrovasc Dis; 2007 Oct 13; 16(6):263-7. PubMed ID: 18035244
    [Abstract] [Full Text] [Related]

  • 10. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP, Lodder J.
    Expert Rev Neurother; 2008 Nov 13; 8(11):1661-5. PubMed ID: 18986236
    [Abstract] [Full Text] [Related]

  • 11. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):752-5. PubMed ID: 16139120
    [Abstract] [Full Text] [Related]

  • 12. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS, Skalabrin EJ, Kraiss LW.
    Am J Ther; 2009 Sep 06; 16(2):164-70. PubMed ID: 19300042
    [Abstract] [Full Text] [Related]

  • 13. Medical treatment of patients with intracranial atherosclerotic disease.
    Gomez CR, Qureshi AI.
    J Neuroimaging; 2009 Oct 06; 19 Suppl 1():25S-9S. PubMed ID: 19807855
    [Abstract] [Full Text] [Related]

  • 14. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
    Bousser MG, Eschwege E, Haguenau M, Lefaucconnier JM, Thibult N, Touboul D, Touboul PJ.
    Stroke; 1983 Oct 06; 14(1):5-14. PubMed ID: 6401878
    [Abstract] [Full Text] [Related]

  • 15. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
    Brechter C, Bäcklund H, Krook H, Müller R, Nitelius E, Olsson JE, Olsson O, Thornberg A.
    Lakartidningen; 1980 Dec 24; 77(52):4947-56. PubMed ID: 7010029
    [No Abstract] [Full Text] [Related]

  • 16. [Controlled clinical trial of the effect of aspirin and aspirin + dipyridamole on the development of diabetic retinopathy. I. General protocol. From the DAMAD Study Group (author's transl)].
    Diabete Metab; 1982 Jun 24; 8(2):91-6. PubMed ID: 7049782
    [Abstract] [Full Text] [Related]

  • 17. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA.
    Am Fam Physician; 2005 Aug 01; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract] [Full Text] [Related]

  • 18. [Secondary prevention after stroke. 2 platelet inhibitors are better than one].
    MMW Fortschr Med; 2002 May 09; 144(19):61. PubMed ID: 12116558
    [No Abstract] [Full Text] [Related]

  • 19. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ.
    Curr Med Res Opin; 2007 Jun 09; 23(6):1453-62. PubMed ID: 17559741
    [Abstract] [Full Text] [Related]

  • 20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 09; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.